POMGNT1 and neuromuscular disease caused by qualitative or quantitative defects of alpha-dystroglycan: Previous investigators have observed altered satellite cell function in various muscular dystrophies, including DMD patients and dystroglycanopathy POMGnT1-null mice [37–40, 48].